These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 326805)

  • 1. Glucose suppression of glucagon: relationship to pancreatic beta cell function?
    Hatfield HH; Banasiak MF; Driscoll T; Kim HJ; Kalkhoff RK
    J Clin Endocrinol Metab; 1977 Jun; 44(6):1080-7. PubMed ID: 326805
    [No Abstract]   [Full Text] [Related]  

  • 2. [A new beta cell efficiency test in the islands of Langerhans].
    Páv J; Srámková J
    Vnitr Lek; 1977 Jun; 23(7):639-46. PubMed ID: 331663
    [No Abstract]   [Full Text] [Related]  

  • 3. Glucagon-like peptide-2 receptor modulates islet adaptation to metabolic stress in the ob/ob mouse.
    Bahrami J; Longuet C; Baggio LL; Li K; Drucker DJ
    Gastroenterology; 2010 Sep; 139(3):857-68. PubMed ID: 20546737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase of beta-endorphin serum levels by human corticotropin-releasing factor does not affect beta-cell function in overweight women.
    Ritter MM; Richter WO; Schwandt P
    Horm Metab Res; 1992 Jul; 24(7):349-50. PubMed ID: 1516893
    [No Abstract]   [Full Text] [Related]  

  • 5. Evidence for an insulin-independent alpha-cell abnormality in human diabetes.
    Bennett PH; Aronoff SL; Unger RH
    Metabolism; 1976 Nov; 25(11 Suppl 1):1527-9. PubMed ID: 790099
    [No Abstract]   [Full Text] [Related]  

  • 6. Dilemmas in diabetes.
    Wolf S; Berle BB
    Adv Exp Med Biol; 1975; 65():1-166. PubMed ID: 813501
    [No Abstract]   [Full Text] [Related]  

  • 7. Relationship between secretory capacity of pancreatic A cell and of B cell.
    Shima K; Tanaka R; Sawazaki N; Kumahara Y
    Horm Metab Res; 1979 Jul; 11(7):451-2. PubMed ID: 383596
    [No Abstract]   [Full Text] [Related]  

  • 8. Acromegaly: insensitivity of the pancreatic alpha cell to hyperglycaemia.
    Seino Y; Taminato T; Goto Y; Inoue Y; Kadowaki S; Mori K; Imura H
    Clin Endocrinol (Oxf); 1978 Dec; 9(6):577-81. PubMed ID: 371862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-endorphin and the endocrine pancreas. Studies in healthy and diabetic human beings.
    Feldman M; Kiser RS; Unger RH; Li CH
    N Engl J Med; 1983 Feb; 308(7):349-53. PubMed ID: 6296674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion.
    Müller WA; Faloona GR; Aguilar-Parada E; Unger RH
    N Engl J Med; 1970 Jul; 283(3):109-15. PubMed ID: 4912452
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of glucagon in diabetes.
    Unger RH; Orci L
    Compr Ther; 1982 Jan; 8(1):53-9. PubMed ID: 7039948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose, insulin and glucagon in the diabetic goose.
    Karmann H; Mialhe P
    Horm Metab Res; 1976 Nov; 8(6):419-26. PubMed ID: 1002101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-kinetics of pancreatic glucagon responses to arginine and glucose in subjects with normal and impaired pancreatic B cell function.
    Assan R; Efendic S; Luft R; Cerasi E
    Diabetologia; 1981 Nov; 21(5):452-9. PubMed ID: 7028559
    [No Abstract]   [Full Text] [Related]  

  • 14. Protective effect of brain-derived neurotrophic factor on pancreatic islets in obese diabetic mice.
    Yamanaka M; Itakura Y; Inoue T; Tsuchida A; Nakagawa T; Noguchi H; Taiji M
    Metabolism; 2006 Oct; 55(10):1286-92. PubMed ID: 16979397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the suppressive effects of elevated plasma glucose and free fatty acid levels on glucagon secretion in normal and insulin-dependent diabetic subjects. Evidence for selective alpha-cell insensitivity to glucose in diabetes mellitus.
    Gerich JE; Langlois M; Noacco C; Lorenzi M; Karam JH; Korsham PH
    J Clin Invest; 1976 Aug; 58(2):320-5. PubMed ID: 783198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective induction of inducible nitric oxide synthase in pancreatic islet of rat after an intravenous glucose or intralipid challenge.
    Ekelund M; Qader SS; Jimenez-Feltstrom J; Salehi A
    Nutrition; 2006 Jun; 22(6):652-60. PubMed ID: 16635563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose and ATP levels in pancreatic islet tissue of normal and diabetic rats.
    Matschinsky FM; Pagliara AS; Stillings SN; Hover BA
    J Clin Invest; 1976 Nov; 58(5):1193-200. PubMed ID: 136453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype.
    Vilsbøll T; Knop FK; Krarup T; Johansen A; Madsbad S; Larsen S; Hansen T; Pedersen O; Holst JJ
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4897-903. PubMed ID: 14557471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetogenic effects of N-nitrosomethylurea in rats.
    Voss C; Herrmann I; Hartmann K; Zühlke H; Besch W; Keilacker H
    Exp Clin Endocrinol; 1988 Sep; 92(1):25-31. PubMed ID: 3068065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of glucose and insulin on glucagon secretion in alloxan diabetic rats.
    Tanese T; Yokoyama J; Narimiya M; Tajima N; Yamada H; Ikeda Y; Abe M
    Horm Metab Res; 1980 Jul; 12(7):290-3. PubMed ID: 6995248
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.